Metabolic and adverse effects of diuretics

Seminars in Nephrology

Volumn 19, Issue 6, 1999, Pages 557-568

  Wilcox, Christopher S ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; KETOCONAZOLE; LITHIUM; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAMIDINE; POTASSIUM CHLORIDE; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; TRIMETHOPRIM;

ACIDOSIS; ALKALOSIS; DIURETIC THERAPY; DRUG HYPERSENSITIVITY; ELECTROLYTE DISTURBANCE; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOVOLEMIA; IMPOTENCE; INTERSTITIAL NEPHRITIS; METABOLIC DISORDER; OTOTOXICITY; PRIORITY JOURNAL; REVIEW; UREMIA;

ANIMALS; DIURETICS; HUMANS; METABOLIC DISEASES; PROGNOSIS; RISK ASSESSMENT; WATER-ELECTROLYTE IMBALANCE;

EID: 0032745958     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Unwin RJ, Capasso G, Wilcox CS: Therapeutic use of diuretics, in Brady HR, Wilcox CS (eds): Therapy in Nephrology and Hypertension. Philadelphia, PA, Saunders, 1998, pp 654-664
2. Ellison D, Wilcox CS: Diuretic resistance. In: Brady HR, Wilcox CS (eds): Therapy in Nephrology and Hypertension. Philadelphia, PA, Saunders, 1998, pp 665-674
3. Wilcox CS, Loon NR, Ameer B, et al: Renal and hemodynamic responses to bumetanide in hypertension: Effects of nitrendipine. Kidney Int 36:719-725, 1989
4. Beutler JJ, Boer WH, Koomans HA, et al: Renal hemodynamic and tubular response to furosemide in man during normal and restricted sodium intake. Nephron 54:208-213, 1990
5. Loon NR, Wilcox CS, Unwin RJ: Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36:682-689, 1989
6. Wilcox CS, Mitch WE, Kelly RA, et al: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 102:450-458, 1983
7. Leth A: Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circ 42:479-485, 1970
8. Wilson IM, Preis ED: Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circ 20:1028-1036, 1959
9. Finnerty FA, Dividov M, Kakaviatos N: Relation of sodium balance to arterial pressure during drug-induced saluresis. Circ 38:175-183, 1968
10. Canton AD, Fuiano G, Conte G, et al: Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci 68:255-261, 1985
11. Kamm DE, Genin M, Kuchmy B, et al: Diuretic-induced azotemia: Unmasking the role of increased peripheral catabolism through evisceration-hepatectomy. Kidney Int Suppl 16: S58-S60, 1983
12. Thomas RD, Newill A, Morgan DB: The cause of the raised plasma urea of acute heart failure. Postgrad Med J 55:10-14, 1979
13. Ayus JC: Diuretic-induced hyponatremia [editorial]. Arch Intern Med 146:1295-1296, 1986
14. Ashraf N, Locksley R, Arieff AI: Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70:1163-1168, 1981
15. Kennedy RM, Earley LE: Profound hyponatremia resulting from a thiazide-induced decrease in urinary diluting capacity in a patient with primary polydipsia. JAMA 282:1185-1186, 1970
16. Friedman E, Shadel M, Halkin H, et al: Thiazide-induced hyponatremia. Ann Intern Med 110:24-30, 1989
17. Fichman MP, Vorherr H, Kleeman CR, et al: Diureticinduced hyponatremia. Ann Intern Med 75:853-863, 1971
18. Sonnenblick M, Friedlander Y, Rosin AJ: Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 103:601-606, 1993
19. Ayus JC, Krothapalli RK, Arieff AI: Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. Am J Med 78:897-902, 1985
20. Norenberg MD, Leslie KO, Robertson AS: Association between rise in serum sodium and central pontine myelinolysis. AnnNeurol 11:128-135, 1982
21. Halterman RK, Berl T: Therapy of dysnatremic disorders, in: Brady HR, Wilcox CS (eds): Therapy in Nephrology and Hypertension. Philadelphia, PA, Saunders, 1998, pp 257-269
22. Ayus JC, Krothapalli RK, Armstrong DL, et al: Symptomatic hyponatremia in rats: Effect of treatment on mortality and brain lesions. Am J Physiol 257:F18-F22, 1989
23. Sterns RH: "Slow" correction of hyponatremia: A break with tradition? Kidney 23:1-5, 1991
24. Ashouri OS: Severe diuretic-induced hyponatremia in the elderly. A series of eight patients. Arch Intern Med 146: 1355-1357, 1986
25. Sterns RH, Cappuccio JD, Silver SM, et al: Neurologic sequelae after treatment of severe hypomatremia: A multicenter perspective. J Am Soc Nephrol 4:1522-1530, 1994
26. Anderson RJ, Chung H-M, Kluge R, et al: Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102:164-168, 1985
27. Kitiyakara C, Wilcox CS. Vasopressin V2-receptor antagonists: Panaceas for hyponatremia? Curr Opin Nephrol Hypertens 6:461-467, 1997
28. Naitoh M, Suzuki H, Murakami M, et al: Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol 267(Heart Circ Physiol 36):H2245-H2254, 1994
29. Fujisawa G, Ishikawa SE, Tsuboi Y, et al: Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 44:19-23, 1993
30. Tsuboi Y, Ishikawa SE, Fujisawa G, et al: Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats. Kidney Int 46:237-244, 1994
31. 2 antagonist OPC-31260 in hydropenic humans. Kidney Int 48:220-226, 1995
32. Ohnishi A, Orita Y, Okahara R, et al: Potent aquarelle agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. J Clin Invest 92:2653-2659, 1993
33. Giebisch G: Renal potassium transport: Mechanisms and regulation. Am J Physiol 274:F817-F833, 1998
34. DuBose T: Effect on acid-base balance, in Eknoyan G, Martinez-Maldonado M (eds): The Physiological Basis of Diuretic Therapy in Clinical Medicine, Orlando, FL, Grune and Stratton, 1986, pp 125
35. Wilcox CS, Mitch WE, Kelly RA, et al: Factors affecting potassium balance during frusemide administration. Clin Sci 67:195-203, 1984
36. Packer M, Medina N, Yushak M: Correction of dilu-tional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Ann Intern Med 100:782-789, 1984
37. Field MJ, Stanton BA, Giebisch GH: Influence of ADH on renal potassium handling: A micropuncture and microperfusion study. Kidney Int 25:502-511, 1984
38. Velazquez H, Wright FS: Control by drugs of renal potassium handling. Annu Rev Pharmacol Toxicol 26:293-309, 1986
39. Wilcox CS: Diuretics and potassium, in Huffman JF, Giebisch G (eds): Current Topics in Membrane and Transport. Orlando, FL, Academic Press, 1987, pp 250-331
40. Morgan DB, Davidson C: Hypokalaemia and diuretics: An analysis of publications. Br Med J 280:905-908, 1980
41. Papademetriou V, Price M, Johnson E, et al: Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol 54:1015-1019, 1984
42. Wilcox CS, Loon NR, Kanthawatana S, et al: Generation of alkalosis during furosemide infusion: Roles of contraction and acid excretion. J Nephrol 2:81-87, 1991
43. Loon NR, Wilcox CS: Mild metabolic alkalosis impairs the natriuretic response to bumetanide in normal human subjects. Clin Sci 94:287-292, 1998
44. Preis ED, Papademetriou V: How dangerous are diuretics? Drugs 30:469-474, 1985
45. Holland OB, Nixon JV, Kuhnert L: Diuretic-induced ventricular ectopic activity. Am J Med 70:762-768, 1981
46. Myers MG: Diuretic therapy and ventricular arrhythmias in persons 65 years of age and older. Am J Cardiol 65:599-603, 1990
47. Robertson JWK, Isles CG, Brown I, et al: Mild hypokalaemia is not a risk factor in treated hypertensives. J Hypertens 4:603-608, 1986
48. Siscovick DS, Raghunathan TE, Psaty B, et al: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330:1852-1857, 1994
49. Hoes AW, Grobbee DE, Lubsen J, et al: Diuretics, beta blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 123:481-487, 1995
50. Siscovick DS, Raghunathan TE, Psaty BM, et al: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330:1852-1857, 1994
51. Siegel D, Hulley SB, Black DM, et al: Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 267:1083-1089, 1992
52. Bergstrom J, Hultman E: The effect of thiazides, chlorthalidone and furosemide on muscle electrolytes and muscle glycogen in normal subjects. Acta Medicina Scandinavica 180:363-376, 1966
53. Rosa RM, Suva P, Young JB, et al: Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 302:431-434, 1980
54. Weinberger MH: Mechanisms of diuretic effects on carbohydrate tolerance, insulin sensitivity and lipid levels. Eur Heart J 13:5-9, 1992
55. Krishna GG, Miller E, Kapoor S: Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 320:1177-1182, 1989
56. Maronde RF, Milgrom M, Vlachakis N, et al: Response to thiazide-induced hypokalemia to amiloride. JAMA 249:237-241, 1983
57. Jeunemaitre X, Chatellier G, Kreft-Jais C, et al: Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60:820-825, 1987
58. Hropot M, Fowler N, Karlmark B, et al: Tubular action of diuretics: Distal effects on electrolyte transport and acidification. Kidney Int 28:477-489, 1985
59. Velazquez H, Perazella MA, Wright FS, et al: Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 119:296-301, 1993
60. Reiser I\V, Chou S-Y, Brown MI, et al: Reversal of trimethoprim-induced antikaliuresis. Kidney Int 50:2063-2069, 1996
61. Schreiber M, Schlanger LE, Chen C-B, et al: Antikaliuretic action of trimethoprim is minimized by raising urine pH. Kidney Int 49:82-87, 1996
62. Quamme GA: Effect of furosemide on calcium and magnesium transport in the rat nephron. Am J Physiol 241:F340-F347, 1981
63. Ryan MP, Devane J, Ryan MF, et al: Effects of diuretics on the renal handling of magnesium. Drugs 28(Suppl 1):167-181, 1984
64. 2+ uptake in mouse distal convoluted tubule cells. Kidney Int 51:1008-1017, 1996
65. Barr CS, Lang CC, Hanson J, et al: Effects of adding spironolactone to an angiotension-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 76:1259-1265, 1995
66. Robinson PJ, Morgan DB, Davidson C, et al: Effects of amiloride and spironolactone on plasma magnesium in frusemide-treated patients with cardiac failure. Br J Pharmacol 88:268, 1984
67. Kroenke K, Wood DR, Hanley JF: The value of serum magnesium determination in hypertensive patients receiving diuretics. Arch Intern Med 147:1553-1556, 1987
68. Petri M, Cumber P, Grimes L, et al: The metabolic effects of thiazide therapy in the elderly: A population study. Age Ageing 15:151-155, 1986
69. Quamme GA: Renal magnesium handling: New insights in understanding old problems. Kidney Int 52:1180-1195, 1997
70. Popovtzer MM, Subryan VL, Alfrey AC, et al: The acute effect of chlorothiazide on serum-ionized calcium. Evidence for a parathyroid hormone-dependent mechanism. J Clin Invest 55:1295-1302, 1975
71. Suki WN: Effects of diuretics on calcium metabolism. Adv Exp Med Biol 151:493-500, 1982
72. Gesek FA, Friedman PA: Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest 90:429-438, 1992
73. Cannon PJ, Heineman HO, Albert MS, et al: "Contraction" alkalosis after diuresis of edematous patients with ethacrynic acid. Ann Intern Med 62:979-990, 1965
74. Levine DZ: Acid-base complications induced by diuretics, in Puschett J, Greenberg A (eds): Diuretics III: Chemistry, Pharmacology, and Clinical Applications. Eisevier Science Publishing Co, Inc, New York, NY, 1990, pp 228-233
75. Miller PD, Berns AS: Acute metabolic alkalosis perpetuating hypercarbia. A role for acetazolamide in chronic obstructive pulmonary disease. JAMA 238:2400-2401, 1977
76. Levine DZ, lacovitti M, Buckman S, et al: Distal tubule unidirectional HC(D, reabsorption in vivo during acute and chronic metabolic alkalosis in the rat. Am J Physiol 266:F919-F925, 1994
77. Krintel JJ, St Haxholdt O, Berthelsen P, et al: Carbon dioxide elimination after acetazolamide in patients with chronic obstructive pulmonary disease and metabolic alkalosis. Acta Anaesthesiol Scand 27:252-254, 1983
78. Ecelbarger CA, Terris J, Hoyer JR, et al: Localization and regulation of the rat renal Na+-K+2Cl~ cotransporter, BSC-1. Am J Physiol 271(Renal Fluid Electrolyte Physiol 40): F619-F628, 1996
79. Fanestil DD, Vaughn DA, Blakely P: Metabolic acid-base influences on renal thiazide receptor density. Am J Physiol 272(Regulatory Integrative Comp Physiol 41):R2004-R200S, 1997
80. Fruman BL: Impairment of glucose intolerance produced by diuretics and other drugs. Pharmacol Ther 12:613, 1981
81. Greenberg G: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet 2:539-543, 1981
82. Dornhorst A, Powell SH, Pensky J: Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet 1:123-126, 1985
83. Murphy MB, Lewis PJ, Kohner E, et al: Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet 1293-1295, 1982
84. Jacobs DB, Mookerjee BK, Jung CY: Furosemide inhibits glucose transport in isolated rat adipocytes via direct inactivation of carrier proteins. J Clin Invest 74:1679-1685, 1984
85. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989
86. Paolisso G, Di Maro G, Cozzolino D, et al: Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. Am J Hypertens 5:681-686, 1992
87. Paolisso G, Gambardella A, Balbi V et al: Effects of magnesium and nifedipine infusions on insulin action, substrate oxidation, and blood pressure in aged hypertensive patients. Am J Hypertens 6:920-926, 1993
88. Haenni A, Andersson PE, Lind L, et al: Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment: Results from a randomized, double-blind study with parallel groups. Am J Hypertens 7:615-622, 1994
89. Rapoport MI, Hurd HF: Thiazide-induced glucose intolerance treated with potassium. Ann Intern Med 113:405-408, 1964
90. Grunfeld C, Chappell DA: Hypokalemia and diabetes mellitus. Am J Med 75:553-554, 1983
91. Ames RP: Hyperlipidemia in hypertension: Causes and prevention. Am Heart J 122:1219-1224, 1991
92. Helderman JH, Elahi D, Andersen DK, et al: Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32:106-111, 1983
93. Rowe JW, Tobin JD, Rosa RM, et al: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29:498-502, 1980
94. Siegel D, Saliba P, Haffner S: Glucose and insulin levels during diuretic therapy in hypertensive men. Hypertens 23:688-694, 1994
95. Curb JD, Pressel SL, Cutler JA: Effects of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAM A 276:1886-1892, 1996
96. Schmilz O, Hermansen K, Nielsen OH, et al: Insulin action in insulin-dependent diabetics after short-term thiazide therapy. Diabetes Care 9:631-636, 1986
97. Ames RP: The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. Drugs 32: 335-357, 1986
98. Ruppert M, Overlack A, Kolloch R, et al: Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults. J Hypertens 11:743-749, 1993
99. Grimm RH, Jr, Flack JM, Grandits GA: Antihypertensive drugs had either a neutral or beneficial effect on lipids. JAMA 275:1549-1556, 1996
100. Manttari M, Tenkanen L, Manninen V, et al: Antihypertensive therapy in dyslipidemic men: Effects on coronary heart disease incidence and total mortality. Hypertension 25: 47-52, 1995
101. Ljunghall S, Backman GB, Danielson B, et al: Effects of bendroflumethiazide on urate metabolism during treatment of patients with renal stones. J Urol 127:1207, 1982
102. Roch-Ramel F, Guisan B, Diezi J: Effects of uricosuric and antiuricosuric agents on urate transport in human brushborder membrane vesicles. J Pharmacol Exp Ther 280:839-845, 1997
103. Langford HG, Blaufox MD, Borhani NO, et al: Is thiazide-induced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 147:645-649, 1987
104. Grimm RH, Grandits GA, Prineas RJ, et al: Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of mild hypertension study (TOMHS). Hypertension 29:8-14, 1997
105. Jensen J, Lendorf A, Stimpel H, et al: The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 12:271-275, 1999
106. Tuzel IH: Comparison of adverse reactions to bumetanide and furosemide. J Clin Pharmacol 21:615-619, 1981
107. Rybak LP, Whitworth C, Scott V: Furosemide ototoxicity is enhanced in analbuminemic rats. Arch Otolaryngol Head Neck Surg 119:758-761, 1993
108. Lindberg BS: Diuretics and pregnancy. Scand J Clin Lab Invest Suppl 169:83-85, 1984
109. Collins R, Yusuf S, Peto R: Overview of randomised trials of diuretics in pregnancy. Br Med J 290:19-23, 1985
110. Davison JM: Edema in pregnancy. Kidney Int 51(Suppl 59):S90-S96, 1997
111. Bailie MD, Linshaw MA, Stygles VG: Diuretic pharmacology in infants and children. Pediatr Clin North Am 217: 231-240, 1981
112. Green TP, Thompson TR, Johnson DE, et al: Furosemide promotes patent ductus arteriousus in premature infants with the respiratory-distress syndrome. N Engl J Med 308:743-748, 1983
113. Hufnagle KG, Khan SN, Penn D, et al: Renal calcifications: A complication of long-term furosemide therapy in preterm infants. Pediatrics 70:360-363, 1982
114. Mulley BA, Parr GD, Pau WK, et al: Placental transfer of chlorthalidone and its elimination in maternal milk. Eur J Clin Pharmacol 13:129-131, 1978
115. Diffey BL, Langtry J: Phototoxic potential of thiazide diuretics in normal subjects. Arch Dermatol 125:1355-1358, 1989
116. Addo HA, Ferguson J, Frain Bell W: Thiazide-induced photosensitivity: A study of 33 subjects. Br J Dermatol 116: 749-760, 1987
117. Heydenreich G, Pindborg T, Schmidt H: Bullous dermatosis among patients with chronic renal failure on high dose frusemide. Acta Med Scand 202:61-64, 1977
118. Cribb AE, Pohl LR, Spielberg SP, et al: Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins. J Pharmacol Exp Ther 282:1064-1072, 1997
119. Frummer JP, Wesson DE, Eknoyan G: Side effects and complications of diuretic therapy, in Eknoyan G, Martinez-Maldonado M: The Physiological Basis of Diuretic Therapy in Clinical Medicine. Orlando, FL, Grune and Stratton, 1986, pp 293-310
120. Giovambattista C, Pica A, Saviano C, et al: Clinical complications of diuretic therapy. Kidney Int 51(Suppl 59): S16-S20, 1997
121. Lyons H, Finn VW, Cortell S, et al: Allergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome. N Engl J Med 288:124-128, 1973
122. Magil AB, Ballon HS, Cameron EC, et al: Acute interstitial nephritis associated with thiazide diuretics. Clinical and pathologic observations in three cases. Am J Med 69:939-943, 1980
123. Lawson DH, Macadam RF, Singh MH, et al: Effect of furosemide on antibiotic-induced renal damage in rats. J Infect Dis 126:593-600, 1972
124. Shapiro S, Slone D, Lewis GP, et al: The epidemiology of digoxin toxicity. A study in three Boston Hospitals. J Chronic Dis 22:361-371, 1969
125. Petersen V, Hvidt S, Thomsen K, et al: Effect of prolonged thiazide treatment on renal lithium clearance. BMJ 3:143-145, 1974
126. Battle DC, von Riotte AB, Gaviria M, et al: Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 312:408-414, 1985
127. Boton R, Gaviria M, Batlle D: Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10:329-345, 1987
128. Weinberg MS, Quigg RJ, Salant DJ, et al: Anuric renal failure precipitated by indomethacin and triamterene. Nephron 40:216-218, 1985